Patients undergoing coronary artery bypass surgery and/or heart valve surgery using a median sternotomy approach coupled with the use of cardiopulmonary bypass often experience pulmonary complications in the postoperative period. These patients are initially monitored in an intensive care unit (ICU) but after discharge from this unit to the ward they may still have compromised pulmonary function. This dysfunction may progress to significant respiratory failure that will cause the patient to return to the ICU. To investigate the severity and incidence of respiratory insufficiency once the patient has been discharged from the ICU to the ward, this study used transcutaneous carbon dioxide monitoring to determine the incidence of unrecognized inadequate ventilation in 39 patients undergoing the current standard of care. The incidence and severity of hypercarbia, hypoxia, and tachycardia in post-cardiac surgery patients during the first 24 hours after ICU discharge were found to be high, with severe episodes of each found in 38%, 79%, and 44% of patients, respectively. R espiratory complications after cardiac surgery have been shown to result in prolonged hospital length of stays and increased costs of care (1, 2) . A retrospective review of these patients at our institution demonstrated a 5% to 10% early intensive care unit (ICU) readmission rate with the main diagnosis of respiratory failure. If the patients at risk could be identifi ed by better monitoring, perhaps an earlier intervention could be made that would prevent the need to return to the ICU and the increased costs involved. To that end, this prospective observational study analyzed the adequacy of ventilation and oxygenation by measuring transcutaneous carbon dioxide (tcpCO 2 ) and peripheral hemoglobin saturation (SpO 2 ) when the postoperative cardiac surgery patient was initially admitted to the ward from the ICU.
METHODS
Institutional hours (e.g., hemodialysis), allergy to the ear probe, or an inability to undergo all protocol requirements. Prior to enrollment, all patients were screened for study eligibility and their medical history was reviewed. Informed consent was obtained preceding any study procedure, and 51 patients were enrolled.
All patients received a standard general anesthetic appropriate for cardiac surgery and were transported to the ICU immediately postoperatively. Following overnight or appropriate recovery in the ICU, patients were discharged to the cardiac telemetry ward, where they received the usual standard of care. To meet discharge criteria, all patients had to be separated from ventilatory support and require only supplemental oxygen via nasal cannula. Th e goals of this study were to determine the incidence of unrecognized respiratory depression during usual and customary care of these patients, and also to determine how well patients tolerated the sensor and how secure it was following placement. Th erefore, the data obtained from the device were not made available to the caregivers, including both the physicians and the bedside nurse, but were recorded and reviewed later.
Upon arrival to the telemetry fl oor, a TOSCA 500 ® or TCM TOSCA ® (Radiometer Medical ApS, Brønshøj, Denmark) monitor was attached to an earlobe of the patient. Th e TOSCA is approved by the US Food and Drug Administration for simultaneous continuous monitoring of tcpCO 2 , functional oxygen saturation, and pulse rate in adults and children (Post Market Approval #K063434). Th e monitor provides information on both oxygen saturation and carbon dioxide levels (3-7). Th e tcpCO 2 reading from the TOSCA has been shown to correlate well with arterial carbon dioxide levels (PaCO 2 ) (8-10). Th e TOSCA probe is attached to the earlobe and is heated to facilitate blood fl ow and capillary vasodilation below the sensor. Th e sensor temperature may be set between 37°C and 45°C in Incidence and severity of respiratory insufficiency detected by transcutaneous carbon dioxide monitoring after cardiac surgery and intensive care unit discharge Elaine E. Lagow, RN, CCRC, Barbara "Bobbi" Leeper, MN, RN, CCRN, Linda W. Jennings, PhD, and Michael A. E. Ramsay, MD steps of 0.5°C with an accuracy of ±0.2°C. Th e manufacturer recommends that the probe be heated to 42°C to adequately enhance blood fl ow, with a change in probe site every 12 hours to prevent thermal burn (9, 11) . Two models of the TOSCA monitor were utilized in this study, the TOSCA 500 and the TCM TOSCA. Th e TOSCA 500 monitor stores all measured patient results every 3 seconds and was used earlier in the study, followed by the TCM TOSCA model, which stores all measured patient results every 10 seconds. Computer software enables data collected from the monitor to be exported to other programs. Th erefore, SpO 2 , tcpCO 2 , and heart rate data every 3 or 10 seconds were available for analysis.
Hypercarbia for this study was classifi ed as mild (tcpCO 2 42-49 mm Hg), moderate (tcpCO 2 50-59 mm Hg), or severe (tcpCO 2 ≥60 mm Hg). Hypoxia for this study was classifi ed as mild (SpO 2 91%-85%), moderate (SpO 2 84%-80%), or severe (SpO 2 ≤79%). Tachycardia for this study was classifi ed as mild (pulse rate 80-90 bpm), moderate (pulse rate 91-119 bpm), or severe (pulse rate ≥120 bpm). Events for the study were cataloged singularly into events of tcpCO 2 ≥60 mm Hg, SpO 2 saturation ≤79%, and pulse rate ≥120 bpm. Events were also cataloged with combinations of SpO 2 saturation of ≤79% with a tcpCO 2 ≥60 mm Hg; SpO 2 saturation of ≤79% with a pulse rate ≥120 bpm; and SpO 2 saturation ≤79% with pulse rate ≥120 bpm plus a tcpCO 2 ≥60 mm Hg.
RESULTS
A total of 51 patients were enrolled in the study, 15 women and 36 men, with a mean age of 63 years. Forty-fi ve of the patients were white or Hispanic and six were black. Twelve of the 51 patients were not included in the fi nal analysis: three withdrew consent prior to the probe being applied; one was in the ICU for an extended period of time and was transferred directly to the rehabilitation hospital, bypassing the telemetry unit; and the remaining eight patients experienced machine malfunction and/or staff error. Twenty-six of the patients were attached to the TOSCA 500 for up to 24 hours from December 2009 through January 2011. Th irteen were attached to the TCM TOSCA for up to 24 hours from March 2012 through October 2012.
Th e total number of actual recorded hours for all 39 patients was 713 hours: 18% of patients had ≤9 hours, 31% had >9 to <20 hours, and 51% had ≥20 hours. Th e tcpCO 2 sensor was functional for a mean of 74% of potential recorded time. Th e O 2 saturation sensor was functional for a mean of 90% of this time. Twelve patients who were connected to the monitors asked to discontinue the study due to the inconvenience of the probe or annoyance with the alarm on the machine. Th e total time monitored in this group was 141 hours. Th ere were three fi les that recorded only the fi rst 12 hours.
One patient returned to the ICU with respiratory distress the third day after transfer to the ward. Th e study was designed to monitor only the fi rst 24 hours posttransfer and therefore did not detect this event when the data were reviewed. However, the patient did exhibit periods of desaturation during the fi rst 8 hours posttransfer, and the oxygen delivery rate was increased from 4 L per minute via nasal cannula to 5 L per minute per nursing unit protocol. Figure 1 summarizes the number of hypercarbic, hypoxic, and tachycardic events, and Table 1 summarizes the duration of these events. Overall, there were 41 moderate or severe hypercarbic events. Th e total duration of tcpCO 2 ≥60 mm Hg was 39.03 ± 72.24 (SD) minutes, ranging from 0.05 to 280 minutes, with a median of 13 minutes. Th e total duration of tcpCO 2 50 to 59 mm Hg was 129.6 ± 218.1 minutes, ranging from 0.05 to 1092 minutes with a median of 67 minutes. Th e total duration of SpO 2 saturation ≤79% in patients experiencing hypoxic episodes was 4.4 ± 9.9 minutes, ranging from 0.1 to 49.7 minutes with a median of 1.1 minute. A pulse rate Severe hypercarbia (≥60 mm Hg) 15 13
Severe oxygen desaturation (≥79%) 31 1.1
Severe tachycardia (≥120 bpm) 17 3.1 Figure 1 . Number of patients experiencing hypercarbic, hypoxic, and tachycardic events among 39 patients monitored after cardiac surgery using transcutaneous carbon dioxide monitoring in the intensive care unit.
≥120 beats/minute occurred in 17 patients, with a total duration of 11.8 ± 20.5 minutes, ranging from 0.1 to 78.0 minutes with a median of 3.1 minutes. Th irty-one percent of these tachycardic patients had a history of atrial fi brillation. As shown in Figure 2 , 21% of the patients experienced all three symptoms of severe hypercarbia, hypoxia, and tachycardia in the fi rst 24 hours after discharge from the ICU.
DISCUSSION
We presented results of 39 postoperative cardiac surgery patients during their fi rst 24 hours following transfer from the ICU to the telemetry fl oor, showing that the incidence and severity of hypercarbia, hypoxia, and tachycardia were high. Th e continuous monitoring of tcpCO 2 , SpO 2 , and pulse rate provides earlier identifi cation of severe respiratory depression, and therefore would lead to earlier intervention and possibly prevent a return to the ICU. Monitoring is particularly important for patients with a history of pulmonary disease, which may increase postoperative complications and ICU stay. A well-tolerated patient monitoring technology that accurately, automatically, and continuously tracks transcutaneous carbon dioxide levels has the potential to greatly improve the timeliness of a response to a failing patient and improve patient safety and outcomes. Th e episodes of severe hypoxia, hypercarbia, and tachycardia detected in this study indicate a need for improved monitoring of this patient population.
Th ere were several limitations to our study. First, although 51 patients agreed to participate, we were able to analyze data for only 39 patients. Of those 39, approximately 76% of potential monitored hours were captured. Th e study monitor TOSCA 500 was upgraded to the TCM TOSCA during the trial. Several patients asked to have the monitor removed early due to continued alarming and comfort level being restricted due to "one more wire" being attached to them. Th e monitor may have been better tolerated by patients if it were wireless. Some of the technical problems encountered may have been avoided with better education for the nursing staff .
Th e clinical signifi cance of our fi ndings will need to be determined by a larger study, where the monitor information is provided to the nurses and an intervention protocol put in place. Monitoring tcpCO 2 , SpO 2 , and pulse rate through a single sensor could provide an advantageous and convenient method of early detection of potential severe respiratory depression. Incidence and severity of respiratory insuffi ciency detected by TcPCO 2 after cardiac surgery and ICU discharge Figure 2 . Percentage of patients experiencing severe-only hypercarbic, hypoxic, and tachycardic events after cardiac surgery based on transcutaneous carbon dioxide monitoring in the intensive care unit.
